GlassScriptPhysician profile
Elizabeth D Rock
NPI 1003952326
$2,090.55
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,255 · 2020: $319 · 2021: $501 · 2022: $15.78.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $647.43 | 2019-2022 | |
| Pfizer INC. | $218.95 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $201.65 | 2019-2021 | |
| Janssen Biotech, INC. | $122.05 | 2019-2021 | |
| Gilead Sciences, INC. | $118.82 | 2019-2020 | |
| Shionogi INC | $112.59 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $108.78 | 2019-2021 | |
| Ucb, INC. | $89.88 | 2019 | |
| Braintree Laboratories, INC. | $88.31 | 2019-2020 | |
| Intercept Pharmaceuticals, INC. | $64.83 | 2019-2021 | |
| Lexicon Pharmaceuticals, INC. | $56.52 | 2019 | |
| Ironwood Pharmaceuticals, INC | $54.59 | 2019-2021 | |
| Celgene Corporation | $49.96 | 2021 | |
| Amgen INC. | $31.59 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $31.47 | 2019-2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $23.69 | 2019 | |
| Novo Nordisk INC | $22.92 | 2019-2020 | |
| Allergan, INC. | $11.98 | 2019 | |
| Medtronic, INC. | $11.81 | 2021 | |
| Concordia Pharmaceuticals INC. | $11.53 | 2019 | |
| Alfasigma USA, INC. | $11.20 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Rock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.